Local secretion of urocortin 1 promotes microvascular permeability during lipopolysaccharide-induced inflammation

Endocrinology

Volumn 150, Issue 12, 2009, Pages 5428-5437

  Cureton, Elizabeth L ^a   Ereso, Alexander Q ^a   Victorino, Gregory P ^a   Curran, Brian ^a   Poole, Daniel P ^a   Liao, Min ^a   Harken, Alden H ^a   Bhargava, Aditi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BACTERIUM LIPOPOLYSACCHARIDE; CD31 ANTIGEN; MICROSPHERE; NEUROPEPTIDE RECEPTOR; RECEPTOR SUBTYPE; STRESS ACTIVATED PROTEIN KINASE; UROCORTIN I;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROMOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; RECEPTOR BLOCKING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VEIN PERMEABILITY; VENULE;

ANILINE COMPOUNDS; ANIMALS; ANTHRACENES; ANTIGENS, CD31; CAPILLARY PERMEABILITY; DRUG SYNERGISM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; INFLAMMATION; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MESENTERY; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UROCORTINS;

EID: 71949089870     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0489     Document Type: Article

References (45)

1. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW 2001 Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570-7575 (Pubitemid 32567989)
2. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE 2001 Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843-2848 (Pubitemid 32209571)
3. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Sawchenko PE, Vale W 1995 Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin- releasing factor. Nature 378:287-292
4. Davidson SM, Yellon DM 2009 Urocortin: a protective peptide that targets both the myocardium and vasculature. Pharmacol Rep 61: 172-182
5. McCarthy JR, Heinrichs SC, Grigoriadis DE 1999 Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Curr Pharm Des 5:289-315
6. Chatzaki E, Crowe PD, Wang L, Million M, Taché Y, Grigoriadis DE 2004 CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J Neurochem 90:309-316 (Pubitemid 38938216)
7. Martínez V, Wang L, Rivier JE, Vale W, Taché Y 2002 Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 301: 611-617 (Pubitemid 34429975)
8. Chatzaki E, Charalampopoulos I, Leontidis C, Mouzas IA, Tzardi M, Tsatsanis C, Margioris AN, Gravanis A 2003 Urocortin in human gastric mucosa: relationship to inflammatory activity. J Clin Endocrinol Metab 88:478-483 (Pubitemid 36115205)
9. Kohno M, Kawahito Y, Tsubouchi Y, Hashiramoto A, Yamada R, Inoue KI, Kusaka Y, Kubo T, Elenkov IJ, Chrousos GP, Kondo M, Sano H 2001 Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J Clin Endocrinol Metab 86:4344-4352 (Pubitemid 32848557)
10. Saruta M, Takahashi K, Suzuki T, Torii A, Kawakami M, Sasano H 2004 Urocortin 1 in colonic mucosa in patients with ulcerative colitis. J Clin Endocrinol Metab 89:5352-5361 (Pubitemid 39518408)
11. Saggi BH, Sugerman HJ, Ivatury RR, Bloomfield GL 1998 Abdominal compartment syndrome. J Trauma 45:597-609
12. Lenz A, Franklin GA, Cheadle WG 2007 Systemic inflammation after trauma. Injury 38:1336-1345
13. O'Keefe GE, Maier RV, Diehr P, Grossman D, Jurkovich GJ, Conrad D 1997 The complications of trauma and their associated costs in a level I trauma center. Arch Surg 132:920 -924; discussion 925 (Pubitemid 27344147)
14. Rivier JE, Kirby DA, Lahrichi SL, Corrigan A, Vale WW, Rivier CL 1999 Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat. J Med Chem 42:3175-3182 (Pubitemid 29384054)
15. Landis E 1927 Micro-injection studies of capillary permeability. II. The relation between capillary pressure and the rate at which fluid passes through the walls of single capillaries. Am J Physiol 82:217-238
16. Sarelius IH, Kuebel JM, Wang J, Huxley VH 2006 Macromolecule permeability of in situ and excised rodent skeletal arterides and venules. Am J Physiol Heart Circ Physiol 290:H474-H480
17. Kendall S, Michel CC 1995 The measurement of permeability in single rat venules using the red cell microperfusion technique. Exp Physiol 80:359-372
18. Baffert F, Le T, Thurston G, McDonald DM 2006 Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am J Physiol Heart Circ Physiol 290:H107-H118
19. Poole DP, Matsuyama H, Nguyen TV, Eriksson EM, Fowler CJ, Furness JB 2007 Inflammation and inflammatory agents activate protein kinase Cε translocation and excite guinea-pig submucosal neurons. Gastroenterology 133:1229-1239 (Pubitemid 47494448)
20. Gavriia AM, Robinson B, Hoy J, Stewart J, Bhargava A, Amir S 2008 Double-stranded RNA-mediated suppression of Period 2 expression in the suprachiasmatic nucleus disrupts circadian locomotor activity in rats. Neuroscience 154:409-414
21. la Fleur SE, Wick EC, Idumalla PS, Grady EF, Bhargava A 2005 Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum. Proc Natl Acad Sci USA 102:7647-7652 (Pubitemid 40741025)
22. Chang J, Hoy JJ, Idumalla PS, Clifton MS, Pecoraro NC, Bhargava A 2007 Urocortin2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis. Peptides 28:1453-1460 (Pubitemid 47088742)
23. Clifton MS, Hoy JJ, Chang J, Idumalla PS, Fakhruddin H, Grady EF, Dada S, Corvera CU, Bhargava A 2007 The role of calcitonin receptor- like receptor in colonic motility and inflammation. Am J Physiol 293:G36-G44
24. Tucker VL, Huxley VH 1988 O2 modulation of single-vessel hydraulic conductance. Am J Physiol 254:H317-H323
25. DeLong ER, DeLong DM, Clarke-Pearson DL 1988 Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845
26. Yeh KC, Kwan KC 1978 A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J Pharmacokinet Biopharm 6:79-98
27. Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM 2003 International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin- releasing factor and their ligands. Pharmacol Rev 55:21-26
28. Assi K, Pillai R, Gómez-Muñoz A, Owen D, Salh B 2006 The specific JNK inhibitor SP600125 targets tumour necrosis factor-α production and epithelial cell apoptosis in acute murine colitis. Immunology 118:112-121
29. Galanos C, Freudenberg MA 1993 Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187:346-356
30. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE 1991 Endotoxemia in human septic shock. Chest 99:169-175
31. Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD 1994 Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179:269-277 (Pubitemid 24012992)
32. Moriez R, Salvador-Cartier C, Theodorou V, Fioramonti J, Eutamene H, Bueno L 2005 Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. Am J Pathol 167:1071-1079 (Pubitemid 41416259)
33. Baldwin Jr AS 1996 The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14:649-683 (Pubitemid 26130197)
34. Siebenlist U, Franzoso G, Brown K 1994 Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405-455
35. Medzhitov R, Preston-Hurlburt P, Janeway Jr CA 1997 A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397 (Pubitemid 27334820)
36. Qureshi ST, Larivière L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D 1999 Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189:615-625 (Pubitemid 29193362)
37. Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, Theoharides TC 1999 Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin- releasing hormone receptors. J Pharmacol Exp Ther 288: 1349-1356 (Pubitemid 29254177)
38. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP 1991 Autocrine or paracrine inflammatory actions of corticotropinreleasing hormone in vivo. Science 254:421-423 (Pubitemid 21917357)
39. Wu Y, Xu Y, Zhou H, Tao J, Li S 2006 Expression of urocortin in rat lung and its effect on pulmonary vascular permeability. J Endocrinol 189:167-178 (Pubitemid 43670711)
40. Tsatsanis C, Androulidaki A, Alissafi T, Charalampopoulos I, Dermitzaki E, Roger T, Gravanis A, Margioris AN 2006 Corticotropin- releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU. 1 and AP-1. J Immunol 176:1869-1877 (Pubitemid 43134332)
41. Gonzalez-Rey E, Chorny A, Varela N, Robledo G, Delgado M 2006 Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response. Am J Pathol 168: 1921-1930 (Pubitemid 43825312)
42. Agnello D, Bertini R, Sacco S, Meazza C, Villa P, Ghezzi P 1998 Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin. Am J Physiol 275:E757-E762 (Pubitemid 28536313)
43. Million M, Maillot C, Saunders P, Rivier J, Vale W, Taché Y 2002 Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats. Am J Physiol 282: G34-G40 (Pubitemid 34650096)
44. Davis RJ 2000 Signal transduction by the JNK group of MAP kinases. Cell 103:239-252
45. Hommes D, van den Blink B, Plasse T, Bartelsman J, Xu C, Macpherson B, Tytgat G, Peppelenbosch M, Van Deventer S 2002 Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology 122: 7-14 (Pubitemid 34049188)